The AutoPap 300 QC system multicenter clinical trials for use in quality control rescreening of cervical smears: II. Prospective and archival sensitivity studies

Stanley F. Patten, James S J Lee, David C. Wilbur, Thomas A. Bonfiglio, Terence J. Colgan, Ralph M. Richart, Harvey Cramer, Shamin Moinuddin

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

BACKGROUND. The AutoPap 300 QC System is an automated device for the analysis of conventional cervical cytology slides. The AutoPap selects an enriched population of cases for quality control review. These studies evaluated the overall sensitivity of AutoPap device to a wider variety of cytologic abnormalities than could be analyzed in the prospective portion of the clinical trials. METHODS. At five clinical trial sites, positive cases were selected from: 1) archives (historic sensitivity study) or 2) current positive cases (current archive sensitivity study). Cases were analyzed by the AutoPap System along with matched negative cases and stratified into detection deciles by instrument score for each diagnostic category. RESULTS. For the historic sensitivity study, the percentages of cases present within the top 10% instrument scores were as follows: atypical glandular cells of undetermined significance (AGUS): 33.7% (n = 243); low grade squamous intraepithelial lesion (LSIL): 57% (n = 412); high grade squamous intraepithelial lesion (HSIL): 81.6% (n = 385); and carcinoma: 77.7% (n = 139). For the current archive sensitivity study, the percentage of cases within the top 10% of instrument scores were as follows: atypical squamous cells of undetermined significance (ASCUS): 37.6% (n = 205); AGUS: 27.3% (n = 22); LSIL: 53.7% (n = 410); HSIL: 80.7% (n = 202); and carcinoma: 62.5% (n = 8). Sensitivities at higher percentiles proportionately were greater. CONCLUSIONS. The AutoPap 300 QC System is detection sensitive, particularly at the level of LSIL and greater. When coupled with the data from the prospective intended use study, these results provided confirmation of the instrument's ability to enhance the false-negative detection rate significantly when compared with a 10% random case selection process. In addition, high sensitivities to all categories of abnormality suggest the possibility of using such instrumentation as a primary screening device for cervical cytology.

Original languageEnglish
Pages (from-to)343-347
Number of pages5
JournalCancer
Volume81
Issue number6
DOIs
StatePublished - Dec 25 1997

Fingerprint

Vaginal Smears
Quality Control
Multicenter Studies
Clinical Trials
Equipment and Supplies
Cell Biology
Carcinoma
Squamous Intraepithelial Lesions of the Cervix
Population

Keywords

  • Automation
  • AutoPap
  • Cervix
  • Cytology
  • Quality control

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

The AutoPap 300 QC system multicenter clinical trials for use in quality control rescreening of cervical smears : II. Prospective and archival sensitivity studies. / Patten, Stanley F.; Lee, James S J; Wilbur, David C.; Bonfiglio, Thomas A.; Colgan, Terence J.; Richart, Ralph M.; Cramer, Harvey; Moinuddin, Shamin.

In: Cancer, Vol. 81, No. 6, 25.12.1997, p. 343-347.

Research output: Contribution to journalArticle

Patten, Stanley F. ; Lee, James S J ; Wilbur, David C. ; Bonfiglio, Thomas A. ; Colgan, Terence J. ; Richart, Ralph M. ; Cramer, Harvey ; Moinuddin, Shamin. / The AutoPap 300 QC system multicenter clinical trials for use in quality control rescreening of cervical smears : II. Prospective and archival sensitivity studies. In: Cancer. 1997 ; Vol. 81, No. 6. pp. 343-347.
@article{27cca96174894bcb924fa645cbabcf76,
title = "The AutoPap 300 QC system multicenter clinical trials for use in quality control rescreening of cervical smears: II. Prospective and archival sensitivity studies",
abstract = "BACKGROUND. The AutoPap 300 QC System is an automated device for the analysis of conventional cervical cytology slides. The AutoPap selects an enriched population of cases for quality control review. These studies evaluated the overall sensitivity of AutoPap device to a wider variety of cytologic abnormalities than could be analyzed in the prospective portion of the clinical trials. METHODS. At five clinical trial sites, positive cases were selected from: 1) archives (historic sensitivity study) or 2) current positive cases (current archive sensitivity study). Cases were analyzed by the AutoPap System along with matched negative cases and stratified into detection deciles by instrument score for each diagnostic category. RESULTS. For the historic sensitivity study, the percentages of cases present within the top 10{\%} instrument scores were as follows: atypical glandular cells of undetermined significance (AGUS): 33.7{\%} (n = 243); low grade squamous intraepithelial lesion (LSIL): 57{\%} (n = 412); high grade squamous intraepithelial lesion (HSIL): 81.6{\%} (n = 385); and carcinoma: 77.7{\%} (n = 139). For the current archive sensitivity study, the percentage of cases within the top 10{\%} of instrument scores were as follows: atypical squamous cells of undetermined significance (ASCUS): 37.6{\%} (n = 205); AGUS: 27.3{\%} (n = 22); LSIL: 53.7{\%} (n = 410); HSIL: 80.7{\%} (n = 202); and carcinoma: 62.5{\%} (n = 8). Sensitivities at higher percentiles proportionately were greater. CONCLUSIONS. The AutoPap 300 QC System is detection sensitive, particularly at the level of LSIL and greater. When coupled with the data from the prospective intended use study, these results provided confirmation of the instrument's ability to enhance the false-negative detection rate significantly when compared with a 10{\%} random case selection process. In addition, high sensitivities to all categories of abnormality suggest the possibility of using such instrumentation as a primary screening device for cervical cytology.",
keywords = "Automation, AutoPap, Cervix, Cytology, Quality control",
author = "Patten, {Stanley F.} and Lee, {James S J} and Wilbur, {David C.} and Bonfiglio, {Thomas A.} and Colgan, {Terence J.} and Richart, {Ralph M.} and Harvey Cramer and Shamin Moinuddin",
year = "1997",
month = "12",
day = "25",
doi = "10.1002/(SICI)1097-0142(19971225)81:6<343::AID-CNCR8>3.0.CO;2-M",
language = "English",
volume = "81",
pages = "343--347",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - The AutoPap 300 QC system multicenter clinical trials for use in quality control rescreening of cervical smears

T2 - II. Prospective and archival sensitivity studies

AU - Patten, Stanley F.

AU - Lee, James S J

AU - Wilbur, David C.

AU - Bonfiglio, Thomas A.

AU - Colgan, Terence J.

AU - Richart, Ralph M.

AU - Cramer, Harvey

AU - Moinuddin, Shamin

PY - 1997/12/25

Y1 - 1997/12/25

N2 - BACKGROUND. The AutoPap 300 QC System is an automated device for the analysis of conventional cervical cytology slides. The AutoPap selects an enriched population of cases for quality control review. These studies evaluated the overall sensitivity of AutoPap device to a wider variety of cytologic abnormalities than could be analyzed in the prospective portion of the clinical trials. METHODS. At five clinical trial sites, positive cases were selected from: 1) archives (historic sensitivity study) or 2) current positive cases (current archive sensitivity study). Cases were analyzed by the AutoPap System along with matched negative cases and stratified into detection deciles by instrument score for each diagnostic category. RESULTS. For the historic sensitivity study, the percentages of cases present within the top 10% instrument scores were as follows: atypical glandular cells of undetermined significance (AGUS): 33.7% (n = 243); low grade squamous intraepithelial lesion (LSIL): 57% (n = 412); high grade squamous intraepithelial lesion (HSIL): 81.6% (n = 385); and carcinoma: 77.7% (n = 139). For the current archive sensitivity study, the percentage of cases within the top 10% of instrument scores were as follows: atypical squamous cells of undetermined significance (ASCUS): 37.6% (n = 205); AGUS: 27.3% (n = 22); LSIL: 53.7% (n = 410); HSIL: 80.7% (n = 202); and carcinoma: 62.5% (n = 8). Sensitivities at higher percentiles proportionately were greater. CONCLUSIONS. The AutoPap 300 QC System is detection sensitive, particularly at the level of LSIL and greater. When coupled with the data from the prospective intended use study, these results provided confirmation of the instrument's ability to enhance the false-negative detection rate significantly when compared with a 10% random case selection process. In addition, high sensitivities to all categories of abnormality suggest the possibility of using such instrumentation as a primary screening device for cervical cytology.

AB - BACKGROUND. The AutoPap 300 QC System is an automated device for the analysis of conventional cervical cytology slides. The AutoPap selects an enriched population of cases for quality control review. These studies evaluated the overall sensitivity of AutoPap device to a wider variety of cytologic abnormalities than could be analyzed in the prospective portion of the clinical trials. METHODS. At five clinical trial sites, positive cases were selected from: 1) archives (historic sensitivity study) or 2) current positive cases (current archive sensitivity study). Cases were analyzed by the AutoPap System along with matched negative cases and stratified into detection deciles by instrument score for each diagnostic category. RESULTS. For the historic sensitivity study, the percentages of cases present within the top 10% instrument scores were as follows: atypical glandular cells of undetermined significance (AGUS): 33.7% (n = 243); low grade squamous intraepithelial lesion (LSIL): 57% (n = 412); high grade squamous intraepithelial lesion (HSIL): 81.6% (n = 385); and carcinoma: 77.7% (n = 139). For the current archive sensitivity study, the percentage of cases within the top 10% of instrument scores were as follows: atypical squamous cells of undetermined significance (ASCUS): 37.6% (n = 205); AGUS: 27.3% (n = 22); LSIL: 53.7% (n = 410); HSIL: 80.7% (n = 202); and carcinoma: 62.5% (n = 8). Sensitivities at higher percentiles proportionately were greater. CONCLUSIONS. The AutoPap 300 QC System is detection sensitive, particularly at the level of LSIL and greater. When coupled with the data from the prospective intended use study, these results provided confirmation of the instrument's ability to enhance the false-negative detection rate significantly when compared with a 10% random case selection process. In addition, high sensitivities to all categories of abnormality suggest the possibility of using such instrumentation as a primary screening device for cervical cytology.

KW - Automation

KW - AutoPap

KW - Cervix

KW - Cytology

KW - Quality control

UR - http://www.scopus.com/inward/record.url?scp=15444340055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15444340055&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0142(19971225)81:6<343::AID-CNCR8>3.0.CO;2-M

DO - 10.1002/(SICI)1097-0142(19971225)81:6<343::AID-CNCR8>3.0.CO;2-M

M3 - Article

C2 - 9438459

AN - SCOPUS:15444340055

VL - 81

SP - 343

EP - 347

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 6

ER -